CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
about
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant womenArtemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapyAssessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionMalaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.Disease burden and the role of pharmacogenomics in African populations.Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection
P2860
Q33869119-E006E34A-2CC0-4754-87B0-7C3F49D0327DQ36290691-7253EC84-9512-4CA4-97DA-8B1F54E883BAQ36316695-593DEF7D-90D0-4303-B043-C93D93558FC7Q36320042-3128537A-48C2-45D2-8EB7-B5B138EE389AQ36898678-14A79B4F-0F4A-4490-BECE-C9F6029C7902Q38772466-1094C98B-6BDF-4333-B277-F316D4338FFBQ41693100-4461A38C-70AC-4999-91F8-3B85154C1081Q51365463-7DCC6874-984B-4A68-AFDE-96C927C0A292Q54935902-6E02B9B4-A078-4BE6-9565-B885EE049284Q56346858-FA1672B1-F972-429E-AF23-AA0BFDB9CEF0
P2860
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CYP2B6*6 genotype and high efa ...... V-malaria-coinfected patients.
@en
type
label
CYP2B6*6 genotype and high efa ...... V-malaria-coinfected patients.
@en
prefLabel
CYP2B6*6 genotype and high efa ...... V-malaria-coinfected patients.
@en
P2093
P2860
P356
P1476
CYP2B6*6 genotype and high efa ...... V-malaria-coinfected patients.
@en
P2093
A A R Kamuhabwa
B A Maganda
E Ngaimisi
O M S Minzi
P2860
P2888
P356
10.1038/TPJ.2015.37
P577
2015-05-12T00:00:00Z
P5875
P6179
1039995041